ENGINEERING CELLS FOR LIFE

Serial Number 97761291
654

Registration Progress

Application Filed
Jan 19, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ENGINEERING CELLS FOR LIFE

Basic Information

Serial Number
97761291
Filing Date
January 19, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
654
Status Date
Jan 10, 2025
Application
Pending
Classes
042

Rights Holder

KSQ Therapeutics, Inc.

03
Address
4 Maguire Road
Lexington, MA 02421

Ownership History

KSQ Therapeutics, Inc.

Original Applicant
03
Lexington, MA

Legal Representation

Attorney
Christina M. Licursi, Esq.

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description
Jan 10, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 2, 2024 CNSL R SUSPENSION LETTER WRITTEN
May 2, 2024 GNSL F LETTER OF SUSPENSION E-MAILED
May 2, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 30, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2024 GNRT O NON-FINAL ACTION E-MAILED
Feb 9, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jan 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 18, 2023 GNRT F NON-FINAL ACTION E-MAILED
Oct 18, 2023 CNRT R NON-FINAL ACTION WRITTEN
Oct 17, 2023 DOCK D ASSIGNED TO EXAMINER
Jan 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Medical and scientific research; providing medical and scientific research information; providing scientific information in the field of cell therapies, biotechnology, and drug development; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields
First Use Anywhere: Jan 5, 2023
First Use in Commerce: Jan 5, 2023

Classification

International Classes
042